<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2996">This was a randomized controlled trial conducted in the Intensive Care-Toxicology Unit of the Clinical Emergency Hospital in Bucharest, that included all patients admitted for acute VPA poisoning (VPA &gt;150 μg/l), in 2014. The patients were randomly allocated in 2 groups to receive standard therapy or 1800 mg of L-carnitine/ day together with standard therapy for 3 days. Plasma levels of valproic acid and ammonemia were determined every six hours. Data was statistically analyzed and the results were considered statistically significant at p &lt; 0.05.</p>
